Background:  Helicobacter pylori colonizes the human stomach and is associated with gastritis and gastroduodenal ulcer and gastric cancer. At present, several diagnostic tests for H. pylori detection are available. Invasive methods requiring gastric endoscopy include rapid urease testing, culture, histology and molecular diagnostics. Non-invasive approaches include faecal antigen detection, serologic testing, urea breath testing and molecular diagnostics. Infection with H. pylori can be effectively treated with proton pump inhibitors and various antibiotics. Clarithromycin is an integral part of first line therapies to treat H. pylori infection. Since clarithromycin is a widely used antimicrobial drug, the prevalence of clarithromycin resistant H. pylori strains is increasing continuously. Resistance to clarithromycin is mainly due to three major point mutations at two positions (A2142C, A2142G, and A2143G) within the peptidyltransferase region of the 23S rRNA of H. pylori.

Description:  BactoReal® Kit H. pylori ClariRes is a non-automated IVD test, based on real-time polymerase chain reaction (PCR), for the qualitative detection of DNA (23S rRNA Gen) of Helicobacter pylori (H. pylori) in combination with the detection of a possible clarithromycin susceptibility. The test allows detection of a H. pylori infection with simultaneous detection of the wild-type (susceptible to clarithromycin) as well as of three most common point mutations (A2142C, A2142G, and A2143G) in the 23S rRNA gene of H. pylori responsible for resistance to treatment with clarithromycin. The wild-type sequence and the mutants are detected and distinguished by melting curve analysis in the FAM/SYBR® Green channel following amplification (see 11. interpretation of the PCR-data). The internal DNA positive control (IC) is also detected in the channel for FAM/SYBR® and is used as DNA extraction and/or as real-time PCR inhibition control. The target for the IC (artificial target DNA) is extracted with the sample or is added to the PCR reaction. Proper specimens are DNA extracts from human gastric tissue biopsies and fresh or frozen stool samples without pre-enrichment. This test is suitable for patients of all ages with suspected infection with H. pylori and is intended as an aid in the diagnosis of infection with this pathogen in combination with patient history and additional clinical information. The test is for professional use only and the use is limited to qualified personnel instructed in real-time PCR and in vitro diagnostic procedures.

BactoReal® Kit H. pylori ClariRes
Order Number Reactions Channel Pathogen Channel IPC Target
DHUB1000 50 SYBR Green
For in vitro diagnostic use
Shipping Temperature: -20 °C to +4 °C
Product Features:
  • Amplification and detection: 23S rRNA gene of Helicobacter pylori and Clarythromycin resistance test
  • CE-IVD Real-time PCR Assay with primern, probes and two positive controls
  • Internal Positive Control System to exclude false-negative results

PCR platforms: BactoReal® Kit H. pylori ClariRes is compatible with the real-time PCR instruments LightCycler® 1.1/1.2/1.5 oder 2.0 Instrument (Roche), LightCycler® 480 (Roche), instruments of the QuantstudioTM series (Thermo Fisher Scientific), ABI® 7500 Real-Time PCR System (Thermo Fisher Scientific) and Magnetic Induction Cycler (MIC; Bio Molecular Systems). Other instruments which are capable of detecting FAM/SYBR® Green and performance of melt curve analysis should be validated for compatibility with the kit.

Frequently Asked Questions:

This kit targets the 23S rRNA gene of Helicobacter pylori via real‑time PCR and simultaneously identifies clarithromycin susceptibility by detecting the wild‑type sequence and three key point mutations (A2142C, A2142G, A2143G) using melting curve analysis in the FAM/SYBR Green channel.
The assay is validated for DNA extracts from human gastric tissue biopsies and fresh or frozen stool samples (without pre‑enrichment).
An internal DNA positive control (IC) is detected in the same FAM/SYBR Green channel. It serves as a control for DNA extraction and PCR inhibition. The kit includes both wild‑type and mutant (A2142G) positive controls.
Validated on LightCycler® 1.x/2.0, LightCycler® 480, QuantStudio™ series, ABI® 7500, and the MIC instrument. Compatible with any system capable of FAM/SYBR Green detection and melting curve analysis.
Analytical LoD95% is 16 copies/reaction (~8 fg DNA) for wild‑type; mutant detection is 3–10× less sensitive. Diagnostic studies show 100% sensitivity and specificity on gastric biopsies; stool samples had 96% sensitivity and 100% specificity.
Store all components at –25 °C to –15 °C and protect from light. Use separate pre‑ and post‑PCR workflows, include extraction negative and PCR negative controls, and follow contamination‑control procedures as per IFU.
BactoReal® , MycoReal® , ParoReal ® and ViroReal® Kits run with the same thermal cycling conditions.